Daniel Shames
Patrimonio netto: - $ in data 31/08/2026
Patrimonio netto: - $ in data 31/08/2026
Daniel Shames is the founder of Carolina Urocorp, Inc. Dr. Shames is an Independent Non-Executive Director at Mereo BioPharma Group Plc since 2022.
Formerly, Dr. Shames was Deputy Director-Office of Drug Evaluation III at the US Food & Drug Administration from 2006 to 2008.
Dr. Shames was President of Daniel A Shames Consulting, Inc. Dr. Shames completed undergraduate studies at Brandeis University and earned a doctorate from Georgetown University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Direttore/Membro del Consiglio | 10/11/2022 |
| Società | Posizione | Fine |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2008 |
Daniel A Shames Consulting, Inc. | Presidente | - |
Carolina Urocorp, Inc. | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Georgetown University School of Medicine
Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Carolina Urocorp, Inc. | |
Daniel A Shames Consulting, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale